PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $121,000 | -80.0% | 11,900 | -79.4% | 0.00% | -75.0% |
| Q2 2020 | $604,000 | +24.8% | 57,900 | +1.0% | 0.01% | 0.0% |
| Q1 2020 | $484,000 | +1.3% | 57,300 | +1.1% | 0.01% | +60.0% |
| Q4 2019 | $478,000 | -22.8% | 56,700 | -1.4% | 0.01% | -28.6% |
| Q3 2019 | $619,000 | -15.3% | 57,500 | 0.0% | 0.01% | -12.5% |
| Q2 2019 | $731,000 | -67.8% | 57,500 | -1.8% | 0.01% | -68.0% |
| Q1 2019 | $2,271,000 | +89.4% | 58,534 | -0.6% | 0.02% | +66.7% |
| Q4 2018 | $1,199,000 | -55.6% | 58,900 | 0.0% | 0.02% | -42.3% |
| Q3 2018 | $2,701,000 | +4478.0% | 58,900 | +5790.0% | 0.03% | +2500.0% |
| Q2 2018 | $59,000 | -13.2% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $68,000 | -31.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $99,000 | -17.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $120,000 | +37.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $87,000 | +8600.0% | 1,000 | +33233.3% | 0.00% | – |
| Q4 2015 | $1,000 | -100.0% | 3 | -100.0% | 0.00% | -100.0% |
| Q1 2015 | $3,011,000 | -6.9% | 12,753 | -25.4% | 0.03% | -8.1% |
| Q4 2014 | $3,235,000 | – | 17,089 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |